Healthleap raises $38M to scale AI platform that flags hospital patients at risk

Healthleap, a startup using AI to identify hospital patients at risk of undiagnosed conditions, has raised $38 million in seed and Series A funding.

The financing includes an $8 million seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The company did not disclose its valuation.

Founded in 2022 in South Africa by siblings Jemima and Josiah Meyer, Healthleap initially built a clinical nutrition tool before pivoting to a broader platform. It connects to hospital electronic health records and uses language models to scan clinicians' notes for signs such as recent weight loss, muscle loss, or difficulty swallowing, then combines that with lab results and vital signs to generate risk scores for additional review. The software does not make diagnoses, the company says, but flags patients who may need closer attention.

The platform is deployed in more than 50 hospitals, with customers including Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare. Josiah Meyer, co-founder and CEO, said Healthleap grew from three hospital partners to more than 50 over the past year (through October 2026), and revenue rose more than 10x in the same period. The startup is also building programs to identify aspiration pneumonia, pressure ulcers, and readmission risk for congestive heart failure, which are undergoing further clinical validation.

Healthleap sells three-year contracts priced by licensed bed count, with an outcome-based pricing model. The company plans to use the new funding for engineering, product, sales, and customer success, and aims to expand coverage to more than 40 major health conditions and eventually move into outpatient and home care.